These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17582773)

  • 21. Synthesis and biological evaluation of new dipyrrolo[3,4-a:3,4-c]carbazole-1,3,4,6-tetraones, substituted with various saturated and unsaturated side chains via palladium catalyzed cross-coupling reactions.
    Hénon H; Anizon F; Golsteyn RM; Léonce S; Hofmann R; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2006 Jun; 14(11):3825-34. PubMed ID: 16460946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1.
    Gazzard L; Williams K; Chen H; Axford L; Blackwood E; Burton B; Chapman K; Crackett P; Drobnick J; Ellwood C; Epler J; Flagella M; Gancia E; Gill M; Goodacre S; Halladay J; Hewitt J; Hunt H; Kintz S; Lyssikatos J; Macleod C; Major S; Médard G; Narukulla R; Ramiscal J; Schmidt S; Seward E; Wiesmann C; Wu P; Yee S; Yen I; Malek S
    J Med Chem; 2015 Jun; 58(12):5053-74. PubMed ID: 25988399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
    Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
    J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-substituted azaindoles as potent inhibitors of Cdc7 kinase.
    Bryan MC; Falsey JR; Frohn M; Reichelt A; Yao G; Bartberger MD; Bailis JM; Zalameda L; Miguel TS; Doherty EM; Allen JG
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2056-60. PubMed ID: 23481650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.
    Neagoie C; Vedrenne E; Buron F; Mérour JY; Rosca S; Bourg S; Lozach O; Meijer L; Baldeyrou B; Lansiaux A; Routier S
    Eur J Med Chem; 2012 Mar; 49():379-96. PubMed ID: 22305342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analogues of antifungal tjipanazoles from rebeccamycin.
    Voldoire A; Moreau P; Sancelme M; Matulova M; Léonce S; Pierré A; Hickman J; Pfeiffer B; Renard P; Dias N; Bailly C; Prudhomme M
    Bioorg Med Chem; 2004 Apr; 12(8):1955-62. PubMed ID: 15051063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and anticancer activity of new pyrrolocarbazoles and pyrrolo-beta-carbolines.
    Laronze M; Boisbrun M; Léonce S; Pfeiffer B; Renard P; Lozach O; Meijer L; Lansiaux A; Bailly C; Sapi J; Laronze JY
    Bioorg Med Chem; 2005 Mar; 13(6):2263-83. PubMed ID: 15830466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indolocarbazole glycosides in inactive conformations.
    Facompré M; Carrasco C; Vezin H; Chisholm JD; Yoburn JC; Van Vranken DL; Bailly C
    Chembiochem; 2003 May; 4(5):386-95. PubMed ID: 12740810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives.
    Moreau P; Gaillard N; Marminon C; Anizon F; Dias N; Baldeyrou B; Bailly C; Pierré A; Hickman J; Pfeiffer B; Renard P; Prudhomme M
    Bioorg Med Chem; 2003 Nov; 11(23):4871-9. PubMed ID: 14604648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of 5-substituted 9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as check point 1 kinase inhibitors.
    Sako Y; Ichikawa S; Osada A; Matsuda A
    Bioorg Med Chem; 2010 Nov; 18(22):7878-89. PubMed ID: 20943405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of thienopyridinones as Chk1 inhibitors.
    Song P; Peng P; Han M; Cao X; Ma X; Liu T; Zhou Y; Hu Y
    Bioorg Med Chem; 2014 Sep; 22(17):4882-92. PubMed ID: 25042558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syntheses and antiproliferative activities of new rebeccamycin derivatives with the sugar unit linked to both indole nitrogens.
    Marminon C; Anizon F; Moreau P; Léonce S; Pierré A; Pfeiffer B; Renard P; Prudhomme M
    J Med Chem; 2002 Mar; 45(6):1330-9. PubMed ID: 11882002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents.
    Pierce LT; Cahill MM; Winfield HJ; McCarthy FO
    Eur J Med Chem; 2012 Oct; 56():292-300. PubMed ID: 22910137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved synthesis of isogranulatimide, a G2 checkpoint inhibitor. Syntheses Of didemnimide C, isodidemnimide A, neodidemnimide A, 17-methylgranulatimide, and isogranulatimides A-C.
    Piers E; Britton R; Andersen RJ
    J Org Chem; 2000 Jan; 65(2):530-5. PubMed ID: 10813968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.
    Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Carrasco C; Ollier M; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
    J Med Chem; 1998 May; 41(10):1631-40. PubMed ID: 9572888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of C-glycosyl pyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as a scaffold for check point kinase 1 inhibitors.
    Ichikawa S; Tatebayashi N; Matsuda A
    J Org Chem; 2013 Dec; 78(23):12065-75. PubMed ID: 24127858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases.
    Smaill JB; Lee HH; Palmer BD; Thompson AM; Squire CJ; Baker EN; Booth RJ; Kraker A; Hook K; Denny WA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):929-33. PubMed ID: 18191399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties.
    Pereira ER; Belin L; Sancelme M; Prudhomme M; Ollier M; Rapp M; Sevère D; Riou JF; Fabbro D; Meyer T
    J Med Chem; 1996 Oct; 39(22):4471-7. PubMed ID: 8893841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aza-analogues of the marine pyrroloquinoline alkaloids wakayin and tsitsikammamines: synthesis and topoisomerase inhibition.
    Legentil L; Lesur B; Delfourne E
    Bioorg Med Chem Lett; 2006 Jan; 16(2):427-9. PubMed ID: 16242321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of novel checkpoint kinase 1 inhibitors by in vitro assays and in human cancer cells treated with topoisomerase inhibitors.
    Ferry G; Studeny A; Bossard C; Kubara PM; Zeyer D; Renaud JP; Casara P; de Nanteuil G; Wierzbicki M; Pfeiffer B; Prudhomme M; Leonce S; Pierré A; Boutin JA; Golsteyn RM
    Life Sci; 2011 Aug; 89(7-8):259-68. PubMed ID: 21736880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.